This event has run. Thank you to our speakers, sponsors, and delegates who joined us for the 2026 summit.

Radiopharm Doses First Patient in Phase I Prostate Cancer Radiotherapy Study
Alpha‑Emitting PSMA Therapies Gain Momentum Across Radiopharma Leaders
Ratio Therapeutics Highlights the Next Wave of Radiopharmaceutical Manufacturing Standards
Radiopharma Veterans From Novartis‑Built Platforms Strengthen Emerging Biotechs
Radiopharma Takes Center Stage as Global Biopharma Partnering Accelerates

Scaling Astatine-211 Supply: Overcoming the Manufacturing Challenges Limiting Clinical Adoption

Scaling Astatine-211 Supply: Overcoming the Manufacturing Challenges Limiting Clinical Adoption

1:30 pm - Thursday 23rd July 2026

Evaluating the infrastructure, production and distribution requirements needed to enable reliable Astatine-211 supply
Addressing the manufacturing and logistical bottlenecks restricting broader clinical development and multi-site trial execution
Developing scalable supply strategies to support the future commercialisation of Astatine-211 radiopharmaceuticals

Speakers:

Daniel Teper

Founder & Chief Executive Officer

NAYA Therapeutics